Figure 6 shows that responders have significantly higher CD8/4T cells, PD-L1 level, CD8/Treg and CD8/CD4 ratios, number of NSCLC-specific T cell clones (TCC), and significantly lower MDSCs. This evidence concerns the gene CD4 and non-small cell lung carcinoma.